PUBLISHER: The Business Research Company | PRODUCT CODE: 1938613
PUBLISHER: The Business Research Company | PRODUCT CODE: 1938613
Animal antibiotics and antimicrobials refer to veterinary medications designed to combat bacteria or microorganisms by either killing them or limiting their growth and multiplication. These medications serve various purposes in animals, including the treatment of clinical diseases, prevention or control of common disease events, and the enhancement of animal growth.
The main types of animal antibiotics and antimicrobials encompass tetracyclines, penicillins, sulfonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antimicrobials and antibiotics. Tetracyclines, for example, are bacteriostatic and function by reversibly binding to bacterial 30S ribosomes, thereby altering the bacterial cytoplasmic membrane. Tetracyclines are administered in various forms, including premixes, oral powder, oral solutions, and injections. These medications find use in both companion and food-producing animals.
Tariffs have influenced the animal antibiotics and antimicrobials market by increasing the cost of imported active pharmaceutical ingredients, veterinary formulations, and manufacturing inputs, thereby impacting pricing and supply stability. The effects are most pronounced in antibiotic-heavy segments such as tetracyclines, penicillin, and cephalosporins, and in regions reliant on imports, including asia-pacific and latin america. Higher tariffs have pressured manufacturers to localize production and diversify sourcing, while also encouraging domestic pharmaceutical capacity expansion. In the long term, tariffs may support regional manufacturing growth and reduce dependency on cross-border antibiotic supply chains.
The animal antibiotics and antimicrobials market research report is one of a series of new reports from The Business Research Company that provides animal antibiotics and antimicrobials market statistics, including animal antibiotics and antimicrobials industry global market size, regional shares, competitors with a animal antibiotics and antimicrobials market share, detailed animal antibiotics and antimicrobials market segments, market trends and opportunities, and any further data you may need to thrive in the animal antibiotics and antimicrobials industry. This animal antibiotics and antimicrobials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The animal antibiotics and antimicrobials market size has grown strongly in recent years. It will grow from $5.64 billion in 2025 to $6.05 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to rising livestock population, increasing prevalence of animal infectious diseases, growth of commercial animal farming, expanding veterinary healthcare infrastructure, historical use of antibiotics for growth promotion.
The animal antibiotics and antimicrobials market size is expected to see strong growth in the next few years. It will grow to $8.03 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to stricter regulations on antimicrobial resistance, growing demand for safe animal-derived food products, increasing companion animal ownership, rising investment in veterinary drug r&d, expansion of preventive animal healthcare practices. Major trends in the forecast period include precision veterinary medicine adoption, sustainable livestock health management, digital monitoring of antimicrobial usage, ai-enabled drug discovery for veterinary antibiotics, smart manufacturing of veterinary pharmaceuticals.
The growing demand for animal-derived food products is fueling the expansion of the animal antibiotics and antimicrobials market. Products such as milk, eggs, and meat are significant sources of nutrition and play a vital role in human diets. Companies and institutions involved in producing these animal-derived foods are concentrating on developing healthy or disease-free herds by using animal antibiotics and antimicrobials as a precautionary measure. For example, a report released by the Food and Agriculture Organization (FAO) in June 2023 indicates that global meat production is expected to rise modestly by 0.8 percent in 2023, reaching 365 million tonnes (carcass weight equivalent) compared to 2022. Consequently, the increasing demand for animal-derived food products is anticipated to drive the demand for animal antibiotics and antimicrobials during the forecast period.
Key players operating in the animal antibiotics and antimicrobials market are focusing on developing innovative solutions, such as novel injectable multi-species treatments, to enhance therapeutic efficacy, improve ease of administration across different livestock species, and address the growing demand for effective disease management solutions amid rising concerns over animal health, productivity, and antimicrobial resistance. A novel injectable multi-species treatment refers to a newly developed injectable medication that is designed to be safely and effectively used across multiple animal species, such as cattle, swine, sheep, or goats, rather than being limited to a single species. For instance, in February 2025, Elanco Animal Health Incorporated, a US-based animal health company, launched Pradalex (pradofloxacin injection), an innovative antibiotic specifically indicated for the treatment of bovine respiratory disease (BRD) and swine respiratory disease (SRD), marking the first new molecule and injectable antibiotic for these indications approved by the U.S. FDA in roughly two decades. Pradalex's novel mode of action enables comprehensive coverage against major BRD and SRD bacteria, delivers high therapeutic concentrations rapidly post-injection, and features an industry-leading withdrawal period, enhancing both efficacy and producer convenience while fitting into integrated disease management programs on farms. This launch underscores how market players are advancing antimicrobial therapies to address significant livestock health challenges, improve animal welfare, and support sustainable production systems.
In July 2024, Merck Sharp & Dohme LLC, a US-based provider of veterinary pharmaceuticals, vaccines, biologicals, and health solutions for livestock, companion animals, and aquaculture, acquired Elanco Animal Health Incorporated's aqua business for an undisclosed amount. With this acquisition, Merck Animal Health aimed to significantly strengthen and scale its global aquaculture portfolio, expand its presence in high-growth aquatic species markets, and enhance its long-term growth strategy in fish health and sustainability solutions. Elanco Animal Health Incorporated is a US-based provider of aquaculture health products, offering vaccines, therapeutics, and nutritional solutions designed to prevent and treat diseases in farmed fish across major aquaculture regions worldwide.
Major companies operating in the animal antibiotics and antimicrobials market are C. H. Boehringer Sohn AG & Co. KG, Zoetis Inc., Elanco Animal Health Inc., Merck & Co. Inc., Phibro Animal Health Corp., Ashish Life Science Pvt. Limited, Ayurvet Limited, Dechra Pharmaceuticals Plc, Huvepharma Inc., Inovet (V. M. D. nv/sa), Kyoritsu Seiyaku Corporation, Lutim Pharma Private Limited, Neogen Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., UCBVET Animal Health, Vetoquinol, Virbac, Zydus Animal Health Limited, China Animal Husbandry Co. Ltd., Norbrook Laboratories Limited, Biovet AD - Peshtera, Bio Agri Mix LP, Bioiberica S. A. U., Ceva Sante Animale
North America was the largest region in the animal antibiotics and antimicrobials market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal antibiotics and antimicrobials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the animal antibiotics and antimicrobials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The animal antibiotics and antimicrobials market consists of sales of glycopeptides, B-Lactam antibiotics, and polymixins. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Animal Antibiotics and Antimicrobials Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses animal antibiotics and antimicrobials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for animal antibiotics and antimicrobials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The animal antibiotics and antimicrobials market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.